WebApr 15, 2024 · Zacks Research analyst S. Ganoria now forecasts that the biopharmaceutical company will earn $1.95 per share for the year, up from their previous estimate of $1.87. The consensus estimate for Novavax's current full-year earnings is ($5.66) per share. A number of other equities research analysts have also recently commented on the stock. WebMay 3, 2024 · We expect Novavax, Inc. NVAX to beat expectations when it reports first-quarter 2024 results on May 9, after the market closes.NVAX’s surprise record has been dismal so far, as its earnings ...
Novavax (NVAX) to Report Q3 Earnings: What
WebApr 12, 2024 · CEO Jacobs took the helm for his inaugural Novavax earnings report during its Q4, 2024 earnings call (the "Call") on 02/28/23. He had taken the helm in replacement of retiring CEO Stanley Erck. WebApr 13, 2024 · Novavax Inc's (NASDAQ: NVAX) CEO, newly appointed CEO John Jacobs, said the company would cut about $50 million in costs in Q1 of 2024 and plans further cuts. "We're looking at everything from ... citizens information jst
Novavax (NVAX) to Report Q2 Earnings: What
WebFeb 22, 2024 · For the last reported quarter, it was expected that Novavax would post earnings of $2.36 per share when it actually produced a loss of $3.21, delivering a … WebMay 3, 2024 · We expect Novavax, Inc. NVAX to beat expectations when it reports first-quarter 2024 results on May 9, after the market closes. NVAX’s surprise record has been … WebFeb 28, 2024 · Novavax: Q4 Earnings Snapshot. February 28, 2024 GMT. GAITHERSBURG, Md. (AP) _ Novavax Inc. (NVAX) on Monday reported a loss of $846.3 million in its fourth quarter. The Gaithersburg, Maryland-based company said it had a loss of $11.18 per share. The results did not meet Wall Street expectations. The average estimate of four analysts … citizens information maternity leave ireland